A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to measure the effect ...

A research team at the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has developed a new ...

A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...

Researchers say CSF biomarker test correlates with the severity of cognitive decline, independent of other factors, including brain amyloid deposition.

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

For decades, research into Alzheimer's disease has been shaped ... mouse model that replicates both tau and beta-amyloid pathologies. "Although both proteins accumulate in the brains of ...

A new model of Alzheimer's disease has been proposed, which could speed up efforts to understand and cure the complex ...